全文获取类型
收费全文 | 1259篇 |
免费 | 83篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 14篇 |
妇产科学 | 15篇 |
基础医学 | 120篇 |
口腔科学 | 20篇 |
临床医学 | 81篇 |
内科学 | 491篇 |
皮肤病学 | 14篇 |
神经病学 | 64篇 |
特种医学 | 73篇 |
外科学 | 203篇 |
综合类 | 7篇 |
预防医学 | 16篇 |
眼科学 | 11篇 |
药学 | 76篇 |
肿瘤学 | 159篇 |
出版年
2022年 | 6篇 |
2021年 | 9篇 |
2020年 | 8篇 |
2019年 | 19篇 |
2018年 | 10篇 |
2017年 | 12篇 |
2016年 | 18篇 |
2015年 | 18篇 |
2014年 | 23篇 |
2013年 | 26篇 |
2012年 | 36篇 |
2011年 | 58篇 |
2010年 | 36篇 |
2009年 | 33篇 |
2008年 | 76篇 |
2007年 | 70篇 |
2006年 | 74篇 |
2005年 | 80篇 |
2004年 | 52篇 |
2003年 | 48篇 |
2002年 | 63篇 |
2001年 | 64篇 |
2000年 | 53篇 |
1999年 | 58篇 |
1998年 | 27篇 |
1997年 | 21篇 |
1996年 | 24篇 |
1995年 | 15篇 |
1994年 | 10篇 |
1992年 | 36篇 |
1991年 | 24篇 |
1990年 | 24篇 |
1989年 | 29篇 |
1988年 | 24篇 |
1987年 | 30篇 |
1986年 | 9篇 |
1985年 | 11篇 |
1984年 | 7篇 |
1980年 | 5篇 |
1979年 | 13篇 |
1978年 | 9篇 |
1975年 | 5篇 |
1974年 | 5篇 |
1973年 | 6篇 |
1972年 | 17篇 |
1971年 | 10篇 |
1969年 | 12篇 |
1968年 | 5篇 |
1967年 | 5篇 |
1966年 | 10篇 |
排序方式: 共有1370条查询结果,搜索用时 468 毫秒
971.
972.
Kuwakado S Takiuchi H Goto M Kawabe S Ohta S Kii T Tanaka T Nishitani H Katsu K 《Gan to kagaku ryoho. Cancer & chemotherapy》2006,33(4):513-515
A 74-year-old man was revealed to have type 3 gastric cancer with synchronous multiple liver metastases. Despite treatment with TS-1 (120 mg/body), an increase in tumor size was demonstrated by computer tomography and endoscopy. We tried a course of a combination chemotherapy consisting of paclitaxel (PTX) plus doxifluridine (5'-DFUR ) to reduce the tumor. 5'-DFUR (600 mg/m(2)) was administered day 1 to 14 followed by 7 days'rest as one course. PTX (80 mg/m(2)) was infused on days 1 and 8. After 5 courses, the tumor markers decreased markedly, and computer tomography and endoscopy revealed remarkable tumor reduction which was thought to show a partial response. After 13 courses we discontinued this chemotherapy, so increase of the tumor marker was remarkable. This case suggests that PTX/5'-DFUR protocol is effective for clinical management of gastric cancer resistant to TS-1. 相似文献
973.
Takiuchi H Kawabe S Goto M Ota S Kii T Tanaka T Nishitani H Kuwakado S Katsu K 《Gan to kagaku ryoho. Cancer & chemotherapy》2006,33(1):19-23
Chemotherapy-induced nausea and vomiting (emesis) can significantly affect a patient's quality of life, leading to poor compliance with further chemotherapy treatment. For patients treated with emetogenic chemotherapy, it is very important to prevent nausea and vomiting completely. The incidence and severity of nausea and/or vomiting in patients receiving chemotherapy are affected by numerous factors, including: 1) the specific chemotherapeutic agents used; 2) their dosage; 3) the schedule and route of administration; and 4) individual patient variability. Approximately 70 to 80% of all cancer patients receiving chemotherapy experience emesis, whereas 10% to 44% experience anticipatory emesis. The following general principles are recommended. 1) A 5-HT3 receptor antagonist should be administered prior to each day's 1st dose of moderately or highly emetogenic chemotherapy. 2) Dexamethasone should be administered once daily either orally or intravenously for every day of moderately or highly-emetogenic chemotherapy and for 2-3 days after chemotherapy for regimens that are likely to cause significant delayed-emesis. 3) The most effective way to treat anticipatory nausea and/or vomiting is to prevent it by using optimal antiemetic therapy during every cycle of treatment. 相似文献
974.
Kawabe M Sasaki M Hirai S Ikeda T Sasaki H Yoshida M Amaya H Aotake T Uchinami M Ihaya A Tanaka K 《Gan to kagaku ryoho. Cancer & chemotherapy》2006,33(1):69-71
A 65-year-old male with liver metastases after lung cancer resection was treated with five courses of chemotherapy consisting of gemcitabine (GEM) 1,000 mg/m2 (day 1, 8, every 4 weeks) plus carboplatin (CBDCA) AUC 6 (day 1, every 4 weeks). A partial response (PR) was achieved, his symptoms abated and his quality of life(QOL) improved. Although bone marrow suppression was observed as a side effect, it was within the tolerable range and did not interfere with therapy. This approach may be worth considering as a first-line anti-cancer chemotherapy for recurrence lung cancer. 相似文献
975.
The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1 总被引:2,自引:0,他引:2
Tanaka Y Kanai F Ichimura T Tateishi K Asaoka Y Guleng B Jazag A Ohta M Imamura J Ikenoue T Ijichi H Kawabe T Isobe T Omata M 《Oncogene》2006,25(4):633-642
Hepatitis B virus X protein (HBx) has many cellular functions and is a major factor in hepatitis and hepatocellular carcinoma caused by HBV infection. A proteomic approach was used to search for HBx-interacting proteins in order to elucidate the molecular mechanism of hepatocarcinogenesis. HBx was attached to myc and flag tags (MEF tags) and expressed in 293T cells; the protein complex formed within the cells was purified and characterized by mass spectrometry. COP9 signalosome (CSN) subunits 3 and 4 were subsequently identified as HBx-interacting proteins. In addition, CSN subunit 5, Jun activation domain-binding protein 1 (Jab1), was shown to be a novel cellular target of HBx. In vivo and in vitro interactions between HBx and Jab1 were confirmed by standard immunoprecipitation and GST pull-down assays. An analysis of HBx deletion constructs showed that amino acids 30-125 of HBx were responsible for binding to Jab1. Confocal laser microscopy demonstrated that HBx was mainly localized in the cytoplasm, while Jab1 was found mainly in the nucleus and partially in the cytoplasm, and that the two proteins colocalized in the cytoplasm. The cotransfection of HBx and Jab1 resulted in substantial activator protein 1 (AP-1) activation and knockdown of endogenous Jab1 attenuated AP-1 activation caused by HBx. In addition, the coexpression of HBx and Jab1 potentiated phosphorylation of JNK, leading to the subsequent phosphorylation of c-Jun, whereas the level of c-Jun and JNK phosphorylation induced by HBx was decreased in Jab1 knockdown cells. These results suggest that the interaction between HBx and Jab1 enhances HBx-mediated AP-1 activation. 相似文献
976.
Soma T Kaganoi J Kawabe A Kondo K Tsunoda S Imamura M Shimada Y 《International journal of cancer. Journal international du cancer》2006,119(4):771-782
Bile acids are known to promote the growth of gastrointestinal cancer. However, the underlying mechanism remains unclear. We examined whether bile acids induce tumor growth via the cyclooxygenase (COX)-2 angiogenic pathway. In vitro, esophageal squamous cell carcinoma (ESCC) cells and esophageal adenocarcinoma cells were studied. Production of prostaglandin E2 (PGE2) and vascular endothelial growth factor (VEGF) in response to treatment with chenodeoxycholic acid (CDCA) was assessed by enzyme-linked immunosorbent assay (ELISA). COX-2 protein and VEGF protein were measured by immunoblot analysis, and COX-2 activity was measured by ELISA. In vivo, CDCA was administered to ESCC cell-bearing mice. Tumor tissues were analyzed immunohistochemically, and microvessel density was evaluated. Clinically, 134 patients with ESCC who underwent esophagectomy were studied. In vitro, CDCA induced the production of PGE2 and VEGF in dose- and time-dependent manners, and these effects were attenuated by a selective COX-2 inhibitor, mitogen-activated protein kinases inhibitor, or epidermal growth factor receptor inhibitor. CDCA-induced COX-2 in the cell lysate increased the secretion of VEGF into the culture medium. In vivo, CDCA markedly enhanced tumor growth and increased vascularization. Clinically, patients whose tumors expressed both COX-2 and VEGF had poor outcomes. Our results suggest that bile acids, important constituents of duodenal fluid, stimulate the development of human esophageal cancer by promoting angiogenesis via the COX-2 pathway. 相似文献
977.
Imai N Doi Y Nabae K Tamano S Hagiwara A Kawabe M Ichihara T Ogawa K Shirai T 《The Journal of toxicological sciences》2006,31(4):357-370
Chronic toxicity and carcinogenicity of hinokitiol (beta-thujaplicin), used as an antibiotic and fungicidal agent of a food additive, was examined in both sexes of F344/DuCrj (F344) rats. In this chronic toxicity study, groups of 10 rats of each sex were given a diet containing hinokitiol at doses of 0, 0.005, 0.015 and 0.05% for 52 weeks. No treatment-related adverse effects were noted in the survival rate, general condition, body weights, food consumption, urinalysis, hematology and clinical chemistry. Slight but significant elevation of spleen and liver weights was noted in both sexes given 0.05% hinokitiol, along with an increase in hemosiderin deposits in male spleens, related to chelator binding of iron, together with slight centrilobular hypertrophy of male hepatocytes. However, these alterations were negligible and not toxicologically significant. In the carcinogenicity study, groups of 50 female and 50 male rats were given a diet containing hinokitiol at doses of 0, 0.005, 0.015 and 0.05% (excluding 0.005% in females). No treatment-related changes in survival rate, general condition, body weight, food consumption, hematology and organ weights were noted. Detailed histopathological examination revealed no treatment-related increase in the incidences of any neoplastic lesions. The results demonstrate that hinokitiol is not carcinogenic in F344 rats of either sex. 相似文献
978.
Matsushima H Kawabe K Fujime M Kitamura T Homma Y Kishi H Kawamura T Umeda T Ohishi Y Murai M Kawai T Yoshida H Fukuda T 《Oncology reports》2002,9(2):283-288
We conducted a randomized controlled trial to compare local recurrence rate after transurethral resection of superficial bladder cancer treated by either intravesical instillation of an anticancer drug alone (method A) and the intravesical instillation plus oral chemotherapy (doxifluridine, 5'-DFUR, an intermediate metabolite of capecitabine) (method B). Results between groups showed no difference in recurrence-free survival curves in 196 patients subjected to primary analysis. However, patients subjected to secondary analysis (method B, over 3 months administration of 5'-DFUR) showed a significantly better prognosis than method A (p=0.0244, Wilcoxon). Regarding correlation between thymidine phosphorylase (TP, an enzyme to convert 5'-DFUR to 5-fluorouracil) level and prognosis, method A patients showed poorer prognosis in higher TP level cases than in lower TP levels. However, there was no significant difference in prognosis between those with higher and lower TP levels. In method B patients, there was no difference in prognosis between those with higher and lower TP levels. Method A patients tended to show a slightly better prognosis than those with lower TP levels, while method B patients tended to have a slightly better prognosis with higher TP levels, but no significant difference was observed. These findings suggested 5'-DFUR showed a mild efficacy in patients with higher TP levels and that patients with higher TP levels resulted in poorer prognosis. 相似文献
979.
980.
T Kitamura N Moriyama K Kawabe Y Aso 《Nihon Hinyōkika Gakkai zasshi. The japanese journal of urology》1989,80(2):197-203
Calcium-containing upper urinary stone formers (group SF-A, n = 116) and normal controls (group Normals, n = 10) were examined for urinary calcium (Ca) and phosphorus (P) excretion (mg/mg creatinine) on usual diet, on Ca-restricted diet and in basal period. As a result, urinary Ca and P excretion decreased significantly both in group SF-A and in normal controls, as the dietary intake was reduced. As compared with normal controls, group SF-A exhibited significant elevation in urinary Ca excretion and showed a slight, though not significant increase, in urinary P excretion. A significant positive correlation between urinary Ca and P excretion was observed in either mode of diet in group SF-A, while no correlation was seen in normal controls. To examine the legitimacy of the result above obtained, another 40 Ca-containing upper urinary stone formers (group SF-B) were studied on usual diet. Thus, better correlation was obtained between urinary Ca and P excretion. In conclusion, urinary Ca and P excretion will be strongly influenced by their dietary intake. Stone formers excrete more Ca and P than normal controls. Finally, a tendency was noted that stone formers excreted the more Ca, the more P. 相似文献